Canada markets open in 3 hours 51 minutes

Stereotaxis, Inc. (STXS)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.8800-0.0900 (-4.57%)
At close: 04:00PM EDT
1.9700 +0.09 (+4.79%)
After hours: 04:53PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.9700
Open1.9900
Bid0.0000 x 800
Ask0.0000 x 1300
Day's Range1.8800 - 1.9995
52 Week Range1.5500 - 3.8800
Volume138,119
Avg. Volume181,928
Market Cap141.086M
Beta (5Y Monthly)1.70
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Broward Health Medical Center the First Hospital in Florida Using Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders

    ST. LOUIS, March 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the grand opening of a new robotic electrophysiology program at Broward Health Medical Center in Fort Lauderdale, Florida. Broward Health is among the first in the nation, and the first in Florida, to offer the latest Genesis Robotic Magnetic Navigation System to treat heart rhythm disorders. “Advancing patient care

  • GlobeNewswire

    Stereotaxis Reports 2022 Full Year Financial Results

    ST. LOUIS, March 03, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the fourth quarter and full year ended December 31, 2022. “This year is poised to be an important and exciting year for Stereotaxis, as we bring multiple strategic innovations to key regulatory and commercial milestones,” said David Fischel, Chairman and CEO. “This transition to a new produc

  • GlobeNewswire

    Stereotaxis to Present at Cowen 43rd Annual Health Care Conference

    ST. LOUIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Cowen 43rd Annual Health Care Conference. Mr. Fischel will present on Stereotaxis’ business and technology during a Fireside Discussion with Josh Jennings, Cowen’s Managing Director & Senior Research Analyst, on Monday, March 6, 2023, at 11:10 am ET. M